A Study on Infectious and Non-Infectious Pulmonary Complications in Autologous Bone Marrow Transplantation

Sangram Keshari Mahapatra, Manoranjan Pattnaik, Rabindra Kumar Jena, Jeetendra Kumar Patra, Bijaya Kumar Meher, Hemanta Kumar Sethy, Thitta Mohanty, Geetanjali Panda, Biswal Pradipta Trilochan, Nrusingha Charan Dash and Paresh Chandra Mahanta
Additional contact information
Sangram Keshari Mahapatra: Department of Pulmonary Medicine, SCB Medical and Hospital, India
Manoranjan Pattnaik: Department of Pulmonary Medicine, SCB Medical and Hospital, India
Rabindra Kumar Jena: Department of Pulmonary Medicine, SCB Medical and Hospital, India
Jeetendra Kumar Patra: Department of Pulmonary Medicine, SCB Medical and Hospital, India
Bijaya Kumar Meher: Department of Pulmonary Medicine, SCB Medical and Hospital, India
Hemanta Kumar Sethy: Department of Pulmonary Medicine, SCB Medical and Hospital, India
Thitta Mohanty: Department of Pulmonary Medicine, SCB Medical and Hospital, India
Geetanjali Panda: Department of Pulmonary Medicine, SCB Medical and Hospital, India
Biswal Pradipta Trilochan: Department of Pulmonary Medicine, SCB Medical and Hospital, India
Nrusingha Charan Dash: Department of Pulmonary Medicine, SCB Medical and Hospital, India
Paresh Chandra Mahanta: Department of Pulmonary Medicine, SCB Medical and Hospital, India

International Journal of Pulmonary & Respiratory Sciences, 2019, vol. 4, issue 3, 54-61

Abstract: Introduction: Bone Marrow Transplantation is a standard therapy for aplastic anaemia, acute leukaemia’s, chronic myelogenous leukaemia, non-Hodgkin’s lymphoma and Hodgkin’s disease with long-term disease-free survival exceeding 60% [1]. Encouraging results are also noted in the role of BMT in the management of hemoglobinopathies, immunodeficiency disorders, myelodysplastic syndromes, multiple myeloma and testicular and breast cancers [1]. Pulmonary complications including infectious and non-infectious conditions which occurs in 40% - 60% of patients who received BMTs, account for meaningful morbidity and mortality.

Keywords: uniper publishers:International Journal of Pulmonary; Journal of Pulmonary Sciences; Journal of Pulmonary & Respiratory Sciences; Pulmonary & Respiratory Sciences; pulmonary & respiratory medicine open access journals; pulmonary & respiratory medicine impact factor journals; pulmonary & respiratory medicine peer review journals; chronic obstructive pulmonary disease; pulmonary arterial hypertension impact factor journals; pulmonary aspergillosis high impact factor journals (search for similar items in EconPapers)
Date: 2019
References: View complete reference list from CitEc
Citations:

Downloads: (external link)
https://juniperpublishers.com/ijoprs/pdf/IJOPRS.MS.ID.555636.pdf (application/pdf)
https://juniperpublishers.com/ijoprs/IJOPRS.MS.ID.555636.php (text/html)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:adp:ijoprs:v:4:y:2019:i:3:p:54-61

DOI: 10.19080/IJOPRS.2019.04.555636

Access Statistics for this article

International Journal of Pulmonary & Respiratory Sciences is currently edited by Sophia Mathis

More articles in International Journal of Pulmonary & Respiratory Sciences from Juniper Publishers Inc.
Bibliographic data for series maintained by Robert Thomas ().